AI in GMP Manufacturing: Are Regulators Ready for Digital Factories?
Learn how AI in pharmaceutical GMP manufacturing is improving quality, data integrity, predictive maintenance, and regulatory compliance in modern drug production.
Endpoints in Gynaecological Oncology Clinical Trials
Gynaecological oncology clinical trials reveal that survival gains and trial design do not always align. Here is what clinical development teams should learn.
Nanocarriers Target the Eye for Better Ocular Drug Delivery
Ocular drug delivery faces major biological barriers. Nanocarriers could improve bioavailability, tissue targeting, controlled release, and treatment for difficult eye diseases.
Mitigation of PFAS Contamination in Pharma Manufacturing
PFAS contamination is a growing manufacturing risk. Explore the latest on the research, wastewater challenges, monitoring, remediation, and pharma implications.
How Should Pharma Companies Audit AI Vendors?
“This is one of the riskiest industries there is because you're dealing with human lives, you're dealing with experimental protocols, and you're dealing with regulatory bodies where you might not get another shot at that clinical trial."
The EU Biotech Act Puts Medical AI Safeguards at a Crossroads
The EU Biotech Act aims to accelerate biotechnology development. Explore how proposed medical AI reforms could affect patient safety, compliance, and pharma competitiveness.